Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis.

Robsahm, Trude Eid; Tretli, Steinar; Torjesen, Peter Abusdal; Babigumira, Ronnie; Schwartz, Gary G

Robsahm, Trude Eid; Tretli, Steinar; Torjesen, Peter Abusdal; Babigumira, Ronnie; Schwartz, Gary G.

Afiliação

Robsahm TE; The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.
Tretli S; The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.
Torjesen PA; The Hormone Laboratory, Department of Endocrinology, Oslo University Hospital Health Authority, Oslo, Norway.
Babigumira R; The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.
Schwartz GG; Department of Population Health, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.

Clin Epidemiol ; 11: 695-705, 2019.

Article em En | MEDLINE | ID: mdl-31496824

Palavras-chave

cancer case fatality; longitudinally; repeated measurement; serum 25-OHD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google